| A PP2A regulatory subunit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation S Padmanabhan, A Mukhopadhyay, SD Narasimhan, G Tesz, MP Czech, ... Cell 136 (5), 939-951, 2009 | 208 | 2009 |
| PDP-1 links the TGF-β and IIS pathways to regulate longevity, development, and metabolism SD Narasimhan, K Yen, A Bansal, ES Kwon, S Padmanabhan, ... PLoS genetics 7 (4), e1001377, 2011 | 91 | 2011 |
| Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells S Pande, G Browne, S Padmanabhan, SK Zaidi, JB Lian, AJ Van Wijnen, ... Journal of cellular physiology 228 (8), 1784-1792, 2013 | 77 | 2013 |
| Nitazoxanide against COVID-19 in three explorative scenarios JM Calderón, MRF Flores, LP Coria, JCB Garduño, JM Figueroa, ... The Journal of Infection in Developing Countries 14 (09), 982-986, 2020 | 48 | 2020 |
| Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t (8; 21) AML signature in leukemic cells DJ Trombly, TW Whitfield, S Padmanabhan, JAR Gordon, JB Lian, ... BMC genomics 16, 1-13, 2015 | 40 | 2015 |
| Potential dual therapeutic approach against SARS-CoV-2/COVID-19 with Nitazoxanide and Hydroxychloroquine M Srivatsan Padmanabhan DO-10.13140/RG. 2.2. 28124.74882, 2020 | 30 | 2020 |
| Treatment with Hydroxychloroquine vs Hydroxychloroquine+ Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: a structured summary of a study protocol for a … JM Calderón, HM Zerón, S Padmanabhan Trials 21, 1-3, 2020 | 23 | 2020 |
| The Coronavirus Disease 2019 (COVID-19) Pan-Syndemic—Will We Ever Learn? S Padmanabhan Clinical Infectious Diseases 73 (9), e2976-e2977, 2021 | 12 | 2021 |
| International pediatric COVID-19 severity over the course of the pandemic Y Zhu, FJ Almeida, JK Baillie, AC Bowen, PN Britton, ME Brizuela, ... JAMA pediatrics 177 (10), 1073-1084, 2023 | 9 | 2023 |
| Nitazoxanide-a potential ally in the treatment of COVID-19 S Padmanabhan, K Padmanabhan ResearchGate: Feb 16, 2021 | 5 | 2021 |
| Potential dual therapeutic approach against SARS-CoV-2/COVID-19 with nitazoxanide and hydroxychloroquine P Srivatsan Preprint, March. https://doi. org/10.13140/RG 2 (28124.74882), 2020 | 4 | 2020 |
| Nitazoxanide–a potential ally in the treatment of COVID-19 M Srivatsan Padmanabhan, KPM Tech | 2 | 2020 |
| Methods of identifying modulators of the pp2a b56 beta regulatory subunit HA Tissenbaum, S Padmanabhan, A Mukhopadhyay, SD Narasimhan US Patent App. 13/120,613, 2011 | 2 | 2011 |
| Treatment with hydroxychloroquine vs nitazoxanide in patients with COVID-19: brief report JM Calderón, S Padmanabhan, FMC Salazar, DC Hernández, ... PAMJ-Clinical Medicine 7 (15), 2021 | 1 | 2021 |
| Treatment with Hydroxychloroquine vs Hydroxychloroquine plus Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol … J Meneses Calderon, H Mendieta Zeron, S Padmanabhan Trials 21 (1), 2020 | | 2020 |
| The COVID-19 Pan-Syndemic–will we ever learn? MD Srivatsan Padmanabhan, S Padmanabhan | | 2020 |
| Abstract B28: Co-occupancy of AML1-ETO and N-CoR defines a dominant phenotypic signature in leukemic cells. DJ Trombly, TW Whitfield, S Padmanabhan, JA Gordon, JB Lian, ... Clinical Cancer Research 21 (17_Supplement), B28-B28, 2015 | | 2015 |
| PDP-1 Links the TGF-b and IIS Pathways to Regulate Longevity SD Narasimhan, K Yen, A Bansal, ES Kwon, S Padmanabhan Development, 2011 | | 2011 |
| Worming to Complete the Insulin/IGF-1 Signaling Cascade: A Dissertation S Padmanabhan | | 2009 |
| A new phosphatase that modulates the C. elegans Insulin/IGF‐1 signaling pathway HA Tissenbaum, S Padmanabhan, A Mukhopadhyay, S Narasimhan The FASEB Journal 23, 93.3-93.3, 2009 | | 2009 |
